false
OasisLMS
Catalog
Worth a Shot? Evidence-Based Approach to Prescribi ...
Presentation and Q&A
Presentation and Q&A
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video is a recording of a webinar titled "Worth a Shot? Evidence-Based Approach to Prescribing LAI Antipsychotic Medications," hosted by SMI Advisor. The webinar is introduced by Donna Rowland, the Director of the Psychiatric Mental Health Nurse Practitioner Program at the University of Texas, Austin. SMI Advisor is an initiative by the American Psychiatric Association (APA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) to provide evidence-based care for those with serious mental illness.<br /><br />The webinar offers one AMA PRA Category 1 Credit for physicians and one Nursing Continuing Professional Development Pharmacology Hour. The presentation discusses the benefits of long-acting injectable (LAI) antipsychotic medications compared to oral formulations in patients with schizophrenia. It explores various studies and meta-analyses that have shown LAIs to be associated with lower risk of treatment failure, rehospitalization, drug discontinuation, violence, and mortality. It also highlights the advantages of LAIs, including convenience, decreased conflict with reminders, and reduced healthcare costs.<br /><br />The presenter, Dr. Leon Raven, a board-certified psychiatrist and Statewide Psychiatric Medical Director for the Division of Public and Behavioral Health, State of Nevada, discusses the benefits of LAIs based on scientific, peer-reviewed evidence. The webinar concludes with a question and answer session. The video includes slides from the presentation, which are available for download in the handouts area of the webinar interface.<br /><br />Note: This summary is based on the provided transcript and does not include any additional comments or information from the speaker that may have been conveyed during the webinar.
Keywords
webinar
LAI antipsychotic medications
schizophrenia
studies
meta-analyses
convenience
healthcare costs
Dr. Leon Raven
question and answer session
×
Please select your language
1
English